Mike Woolcock serves as senior vice president of the Apotex Biosimilar and Specialty Products line of business. Mike has more than 35 years of experience managing various aspects of pharmaceutical and biotech products. He has worked in small and large pharmaceutical companies as well as start-up and large biotechnology companies. In addition, to his commercial experience Mike has spent time in R&D roles within the industry globally. He provides the company with valuable insight into the evolving landscape. Tapping into his deep understanding of development and commercialization, he offers strategic input to support commercial planning for the products of interest.

Mike has been a member of Apotex for over twelve years. He has held roles with increasing responsibilities and helped to boost the company’s growth by building strong relationships with strategic customers and providing management leadership to successfully launch new products, increase relationships with key stakeholders and advance the Apotex market position.

Prior to joining Apotex, Mike held sales, marketing and R&D positions with Procter & Gamble and, biotech companies Cortech and Amgen. Mike earned his BSc in Biochemistry and Genetics from La Trobe University, Melbourne, Australia.